查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1946987

即時檢測（POC​​T）全球市場報告（2026年）

Point-Of-Care-Testing (POCT) Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，即時檢測（POC​​T）市場規模快速擴張，預計將從2025年的507.9億美元成長到2026年的566.8億美元，複合年成長率（CAGR）為11.6%。過去幾年的成長可歸因於多種因素，例如慢性病盛行率上升、對快速臨床決策的需求日益成長、急診和重症監護服務的擴展、中心檢查室資源有限以及對即時診斷結果的需求。

預計未來幾年，即時檢測（POC​​T）市場將快速成長，到2030年市場規模將達到869.1億美元，複合年成長率（CAGR）為11.3%。預測期內的成長要素包括POCT設備小型化程度的不斷提高、居家醫療和遠端患者監護的普及、感染疾病疫情的增加、醫療保健的去中心化程度的提高以及自我檢測的日益普及。預測期內的主要趨勢包括：即時快速診斷檢測的普及、對家庭和自我檢測解決方案的需求不斷成長、市售診斷產品的種類日益豐富、對疾病早期檢測和篩檢的日益重視以及POCT設備準確性和靈敏度的提高。

預計未來幾年，遠端醫療的日益普及將推動就地檢驗（POC​​T）市場的成長。遠端醫療是指利用視訊通話、電話諮詢和安全通訊等數位通訊技術遠端提供醫療服務。尤其是在新冠疫情爆發後，由於人們對便利、及時和非接觸式醫療服務的需求激增，遠距醫療的普及速度顯著加快。 POCT能夠快速可靠地將診斷結果即時共用給遠端醫療的發展。例如，根據美國醫院協會（美國專業組織）2025年4月發布的報告，2023年超過12.6%的聯邦醫療保險受益人使用了遠端醫療服務。預計到2036年，美國醫生數量將達到8.6萬人，凸顯了遠端醫療在解決日益嚴重的醫生短缺問題方面的重要角色。因此，遠端醫療的日益普及正在推動POCT市場的成長。

為了滿足基層醫療對更快速的臨床級診斷和更有效的抗生素管理日益成長的需求，就地檢驗(POCT) 市場的主要企業正日益關注微流體快速抗菌藥物敏感性測試 (AST) 系統等技術創新。微流體AST 技術利用微米級流體通道培養和檢測尿液等患者檢體中的細菌，其抗生素敏感性測定速度遠快於通常需要數天的傳統培養方法。例如，2023 年 6 月，日本診斷設備製造商 Sysmex 公司發布了 PA 100 AST 系統。這款緊湊型 POCT 分析儀採用 Sysmex Astrego 的專有微流體晶片，可在約 15 分鐘內完成細菌檢測，並在約 30 分鐘內提供完整的 AST 結果。此系統操作極為簡便。醫護人員只需將檢體放入一次性晶片，然後將其置於桌上型分析儀中，即可獲得自動化的 AST 結果，無需接受專業的檢查室培訓。快速提供檢測結果有助於在首次就診時選擇合適的抗生素，從而減少不恰當的處方，對抗抗菌素抗藥性（AMR）。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球即時檢測（POC​​T）市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 人工智慧（AI）和自主人工智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 物聯網、智慧基礎設施和互聯生態系統
    • 生物技術、基因組學和精準醫學
    • 工業4.0和智慧製造
  • 主要趨勢
    • 提高即時診斷檢測的普及率
    • 對家用和自測解決方案的需求日益成長
    • 擴大市售診斷產品的範圍
    • 越來越重視疾病的早期檢測和篩檢
    • 提高即時檢測設備的準確性和靈敏度

第5章 終端用戶產業市場分析

  • 醫院
  • 臨床檢查室
  • 門診診所和醫生辦公室
  • 居家照護和自我檢測客戶
  • 藥局

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球即時檢測（POC​​T）市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球即時檢測（POC​​T）市場規模、對比及成長率分析
  • 全球即時檢測（POC​​T）市場表現：規模與成長，2020-2025年
  • 全球即時檢測 (POCT) 市場預測：規模與成長，2025-2030 年，2035 年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按類型
  • 血糖檢測、傳染病檢查、心臟標記檢測、血液凝固檢驗、懷孕/不孕症檢測、血液氣體/電解質檢測、尿液檢查等。
  • 透過購買方式
  • 非處方藥和處方箋藥
  • 透過技術
  • 免疫檢測、分子診斷、微生物檢測、聚合酵素鏈鎖反應(PCR) 檢測、生物化學檢驗
  • 最終用戶
  • 臨床檢查室、門診護理機構和醫生辦公室、藥房、零售診所和電子商務平台、醫院、重症監護中心、急診中心、居家醫療和自我檢測以及其他終端用戶
  • 依類型細分：血糖檢測
  • 自我監測血糖儀、連續血糖儀、瞬感血糖儀
  • 按類型細分：傳染病檢查
  • 人類免疫力缺乏病毒（HIV）檢測、肝炎檢測、流感檢測、新冠病毒檢測和其他傳染病檢查
  • 按類型細分：心臟標記檢測
  • 肌鈣蛋白檢測、肌酸激酶-MB (CK-MB) 檢測、肌紅蛋白檢測、B型鈉尿肽 (BNP) 檢測
  • 按類型細分：血液凝固檢驗
  • 凝血酶原時間 (PT) 檢測、活化部份凝血活酵素時間(aPTT) 檢測、國際標準化比值 (INR) 檢測
  • 按類型細分：妊娠和生育力檢測
  • 檢測套組、排卵檢測套組、生殖激素測試
  • 按類型細分：血氣或電解質檢測
  • 動脈血氣分析、靜脈血氣分析、電解質檢查
  • 按類型細分：尿液檢查
  • 尿液化學分析、尿液顯微鏡檢查及尿液培養
  • 按類型細分：其他類型
  • 藥物濫用檢測、過敏檢測、膽固醇檢測、甲狀腺功能檢測

第10章 區域與國家分析

  • 全球即時檢測（POC​​T）市場：區域表現及預測，2020-2025年、2025-2030年預測、2035年預測
  • 全球即時檢測 (POCT) 市場：國家/地區、市場表現及預測，2020-2025 年、2025-2030 年預測、2035 年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 即時檢測（POC​​T）市場：競爭格局與市場佔有率，2024年
  • 即時檢測（POC​​T）市場：公司估值矩陣
  • 即時檢測（POC​​T）市場：公司概況
    • Johnson & Johnson
    • F. Hoffmann-La Roche Ltd.
    • Abbott Laboratories
    • Danaher Corporation
    • Siemens Healthineers AG

第37章：其他領先和創新企業

  • Becton Dickinson and Company, BioMerieux SA, QuidelOrtho Corporation, Sysmex Corporation, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, Sinocare Inc., Menarini Diagnostics, Princeton BioMeditech, Helena Laboratories, Chembio Diagnostics, ARKRAY

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年即時檢測（POC​​T）市場：提供新機會的國家
  • 2030年即時檢測（POC​​T）市場：充滿新機會的細分市場
  • 即時檢測 (POCT) 市場 2030 年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MPOCT02_G26Q1

Point-of-care testing (POCT) refers to diagnostic testing conducted at or near the site of patient care, providing immediate results and enabling faster clinical decision-making. Its purpose is to deliver quick and accurate diagnostic information directly at the point of care, facilitating timely treatment and improved patient outcomes.

The primary types of point-of-care testing (POCT) include blood glucose testing, infectious disease testing, cardiac marker testing, coagulation testing, pregnancy and fertility testing, blood gas or electrolyte testing, urinalysis testing, and others. Blood glucose testing involves measuring the amount of sugar (glucose) in a person's blood to monitor and manage related conditions. POCT products are available through various purchase modes, including over-the-counter and prescription-based products, and utilize technologies such as immunoassays, molecular diagnostics, microbial detection, polymerase chain reaction (PCR) testing, and biochemical testing. Key end users include clinical laboratories, ambulatory care facilities, physician offices, pharmacies, retail clinics, e-commerce platforms, hospitals, critical care centers, urgent care centers, home care and self-testing, and others.

Tariffs have influenced the point-of-care testing market by increasing costs of imported diagnostic devices, reagents, and electronic components used in POCT systems. Segments such as molecular diagnostics, PCR testing, and immunoassay-based devices are most affected, particularly in Asia-Pacific and North America where cross-border trade of medical diagnostics is high. These cost pressures have impacted pricing and slowed adoption in cost-sensitive markets. However, tariffs have also encouraged local manufacturing, regional supply chain development, and innovation in cost-effective POCT solutions.

The point-of-care-testing (poct) market research report is one of a series of new reports from The Business Research Company that provides point-of-care-testing (poct) market statistics, including point-of-care-testing (poct) industry global market size, regional shares, competitors with a point-of-care-testing (poct) market share, detailed point-of-care-testing (poct) market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care-testing (poct) industry. This point-of-care-testing (poct) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point-of-care-testing (poct) market size has grown rapidly in recent years. It will grow from $50.79 billion in 2025 to $56.68 billion in 2026 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing need for rapid clinical decision making, growth in emergency and critical care services, limited access to centralized laboratories, demand for immediate diagnostic results.

The point-of-care-testing (poct) market size is expected to see rapid growth in the next few years. It will grow to $86.91 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to advancement in poct device miniaturization, expansion of home care and remote patient monitoring, growing infectious disease outbreaks, increasing healthcare decentralization, rising adoption of self-testing diagnostics. Major trends in the forecast period include growing adoption of rapid diagnostic testing at point of care, rising demand for home-based and self-testing solutions, expansion of over-the-counter diagnostic products, increasing focus on early disease detection and screening, improved accuracy and sensitivity of poct devices.

The growing adoption of telemedicine is expected to drive the growth of the point-of-care testing (POCT) market in the coming years. Telemedicine involves delivering medical care remotely using digital communication technologies such as video calls, phone consultations, or secure messaging. Its adoption has accelerated due to rising demand for convenient, timely, and contact-free healthcare services, particularly following the COVID-19 pandemic. POCT supports telemedicine by providing rapid and reliable diagnostic results that can be shared instantly with remote healthcare providers, enabling timely clinical decisions. For example, in April 2025, the American Hospital Association, a U.S.-based professional organization, reported that in 2023, over 12.6% of Medicare beneficiaries utilized telehealth services. By 2036, the number of physicians is projected to reach 86,000, highlighting telehealth's crucial role in addressing the growing physician shortage. Consequently, the increasing adoption of telemedicine is fueling the growth of the POCT market.

Major companies in the point-of-care testing (POCT) market are increasingly emphasizing technological innovations, such as microfluidic rapid antimicrobial-susceptibility testing (AST) systems, to meet the growing demand for faster, clinic-level diagnostics and enhanced antimicrobial stewardship in primary care. Microfluidic AST technology uses micrometer-scale fluid channels to culture and detect bacteria from patient samples-such as urine-and determine their antibiotic susceptibility far more quickly than conventional culture-based methods, which typically take several days. For instance, in June 2023, Sysmex Corporation, a Japan-based diagnostics company, launched the PA 100 AST System, a compact POCT analyzer that uses Sysmex Astrego's proprietary microfluidic cartridges to detect bacteria in roughly 15 minutes and deliver complete AST results in about 30 minutes. The system is highly user-friendly: healthcare professionals place the sample into a single-use cartridge, insert it into the desktop analyzer, and receive automated AST readouts without requiring specialized laboratory training. This rapid turnaround enables timely antibiotic decisions during the initial patient visit, supporting efforts to reduce inappropriate prescriptions and combat antimicrobial resistance (AMR).

In August 2024, Quest Diagnostics Inc., a US-based medical laboratory company, acquired LifeLabs LP for $1 billion (CAN $1.35 billion). This acquisition expands Quest Diagnostics' POCT offerings and strengthens access to innovative diagnostic solutions. LifeLabs LP is a Canada-based provider of point-of-care testing services.

Major companies operating in the point-of-care-testing (poct) market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, BioMerieux SA, QuidelOrtho Corporation, Sysmex Corporation, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, Sinocare Inc., Menarini Diagnostics, Princeton BioMeditech, Helena Laboratories, Chembio Diagnostics, ARKRAY, Accriva, ACON Laboratories, Sekisui Diagnostics, PTS Diagnostics, Meridian Bioscience

North America was the largest region in the point-of-care testing (POCT) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care-testing (poct) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the point-of-care-testing (poct) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The point-of-care testing (POCT) market includes revenues earned by entities by providing services such as on-site diagnostic testing, rapid disease detection, mobile health screening, and patient self-testing support. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care testing (POCT) market includes sales of portable HbA1c analyzers, handheld blood gas analyzers, CRP (C-reactive protein) test kits, multiplex respiratory pathogen detection kits, and lateral flow urine analysis devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point-Of-Care-Testing (POCT) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses point-of-care-testing (poct) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point-of-care-testing (poct) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point-of-care-testing (poct) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Blood Glucose Testing; Infectious Diseases Testing; Cardiac Markers Testing; Coagulation Testing; Pregnancy And Fertility Testing; Blood Gas Or Electrolytes Testing; Urinalysis Testing; Other Types
  • 2) By Mode Of Purchase: Over-The-Counter Products; Prescribed Based Products
  • 3) By Technology: Immunoassays; Molecular Diagnostics; Microbial Detection; Polymerase Chain Reaction (PCR) Testing; Biochemical Testing
  • 4) By End-User: Clinical Laboratories; Ambulatory Care Facilities And Physician Offices; Pharmacies; Retail Clinics And E-Comm Platforms; Hospitals; Critical Care Centres; Urgent Care Centres; Home Care And Self-Testing; Other End-Users
  • Subsegments:
  • 1) By Blood Glucose Testing: Self-Monitoring Blood Glucose Devices; Continuous Glucose Monitoring Devices; Flash Glucose Monitoring Devices
  • 2) By Infectious Diseases Testing: Human Immunodeficiency Virus (HIV) Testing; Hepatitis Testing; Influenza Testing; COVID-19 Testing; Other Infectious Diseases Testing
  • 3) By Cardiac Markers Testing: Troponin Testing; Creatine Kinase-MB (CK-MB) Testing; Myoglobin Testing; B-type Natriuretic Peptide (BNP) Testing
  • 4) By Coagulation Testing: Prothrombin Time (PT) Testing; Activated Partial Thromboplastin Time (aPTT) Testing; International Normalized Ratio (INR) Testing
  • 5) By Pregnancy And Fertility Testing: Pregnancy Test Kits; Ovulation Test Kits; Fertility Hormone Testing
  • 6) By Blood Gas Or Electrolytes Testing: Arterial Blood Gas Testing; Venous Blood Gas Testing; Electrolyte Testing
  • 7) By Urinalysis Testing: Urine Chemistry Analysis; Microscopic Urine Analysis; Urine Culture Testing
  • 8) By Other Types: Drug Abuse Testing; Allergy Testing; Cholesterol Testing; Thyroid Function Testing
  • Companies Mentioned: Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Becton Dickinson and Company; BioMerieux SA; QuidelOrtho Corporation; Sysmex Corporation; Nova Biomedical Corporation; LifeScan Inc.; Ascensia Diabetes Care Holdings AG; Trividia Health Inc.; Trinity Biotech Plc; Sinocare Inc.; Menarini Diagnostics; Princeton BioMeditech; Helena Laboratories; Chembio Diagnostics; ARKRAY; Accriva; ACON Laboratories; Sekisui Diagnostics; PTS Diagnostics; Meridian Bioscience
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Point-Of-Care-Testing (POCT) Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Point-Of-Care-Testing (POCT) Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Point-Of-Care-Testing (POCT) Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Point-Of-Care-Testing (POCT) Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.4 Biotechnology, Genomics & Precision Medicine
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Growing Adoption Of Rapid Diagnostic Testing At Point Of Care
    • 4.2.2 Rising Demand For Home-Based And Self-Testing Solutions
    • 4.2.3 Expansion Of Over-The-Counter Diagnostic Products
    • 4.2.4 Increasing Focus On Early Disease Detection And Screening
    • 4.2.5 Improved Accuracy And Sensitivity Of Poct Devices

5. Point-Of-Care-Testing (POCT) Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinical Laboratories
  • 5.3 Ambulatory Care Facilities And Physician Offices
  • 5.4 Home Care And Self-Testing Users
  • 5.5 Pharmacies

6. Point-Of-Care-Testing (POCT) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Point-Of-Care-Testing (POCT) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Point-Of-Care-Testing (POCT) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Point-Of-Care-Testing (POCT) Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Point-Of-Care-Testing (POCT) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Point-Of-Care-Testing (POCT) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Point-Of-Care-Testing (POCT) Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Point-Of-Care-Testing (POCT) Market Segmentation

  • 9.1. Global Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy And Fertility Testing, Blood Gas Or Electrolytes Testing, Urinalysis Testing, Other Types
  • 9.2. Global Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Over-The-Counter Products, Prescribed Based Products
  • 9.3. Global Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Immunoassays, Molecular Diagnostics, Microbial Detection, Polymerase Chain Reaction (PCR) Testing, Biochemical Testing
  • 9.4. Global Point-Of-Care-Testing (POCT) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Clinical Laboratories, Ambulatory Care Facilities And Physician Offices, Pharmacies, Retail Clinics And E-Comm Platforms, Hospitals, Critical Care Centres, Urgent Care Centres, Home Care And Self-Testing, Other End-Users
  • 9.5. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Blood Glucose Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices, Flash Glucose Monitoring Devices
  • 9.6. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Infectious Diseases Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Human Immunodeficiency Virus (HIV) Testing, Hepatitis Testing, Influenza Testing, COVID-19 Testing, Other Infectious Diseases Testing
  • 9.7. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Cardiac Markers Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Troponin Testing, Creatine Kinase-MB (CK-MB) Testing, Myoglobin Testing, B-type Natriuretic Peptide (BNP) Testing
  • 9.8. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Coagulation Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Prothrombin Time (PT) Testing, Activated Partial Thromboplastin Time (aPTT) Testing, International Normalized Ratio (INR) Testing
  • 9.9. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Pregnancy And Fertility Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pregnancy Test Kits, Ovulation Test Kits, Fertility Hormone Testing
  • 9.10. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Blood Gas Or Electrolytes Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Arterial Blood Gas Testing, Venous Blood Gas Testing, Electrolyte Testing
  • 9.11. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Urinalysis Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Urine Chemistry Analysis, Microscopic Urine Analysis, Urine Culture Testing
  • 9.12. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug Abuse Testing, Allergy Testing, Cholesterol Testing, Thyroid Function Testing

10. Point-Of-Care-Testing (POCT) Market Regional And Country Analysis

  • 10.1. Global Point-Of-Care-Testing (POCT) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Point-Of-Care-Testing (POCT) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Point-Of-Care-Testing (POCT) Market

  • 11.1. Asia-Pacific Point-Of-Care-Testing (POCT) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Point-Of-Care-Testing (POCT) Market

  • 12.1. China Point-Of-Care-Testing (POCT) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Point-Of-Care-Testing (POCT) Market

  • 13.1. India Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Point-Of-Care-Testing (POCT) Market

  • 14.1. Japan Point-Of-Care-Testing (POCT) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Point-Of-Care-Testing (POCT) Market

  • 15.1. Australia Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Point-Of-Care-Testing (POCT) Market

  • 16.1. Indonesia Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Point-Of-Care-Testing (POCT) Market

  • 17.1. South Korea Point-Of-Care-Testing (POCT) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Point-Of-Care-Testing (POCT) Market

  • 18.1. Taiwan Point-Of-Care-Testing (POCT) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Point-Of-Care-Testing (POCT) Market

  • 19.1. South East Asia Point-Of-Care-Testing (POCT) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Point-Of-Care-Testing (POCT) Market

  • 20.1. Western Europe Point-Of-Care-Testing (POCT) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Point-Of-Care-Testing (POCT) Market

  • 21.1. UK Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Point-Of-Care-Testing (POCT) Market

  • 22.1. Germany Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Point-Of-Care-Testing (POCT) Market

  • 23.1. France Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Point-Of-Care-Testing (POCT) Market

  • 24.1. Italy Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Point-Of-Care-Testing (POCT) Market

  • 25.1. Spain Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Point-Of-Care-Testing (POCT) Market

  • 26.1. Eastern Europe Point-Of-Care-Testing (POCT) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Point-Of-Care-Testing (POCT) Market

  • 27.1. Russia Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Point-Of-Care-Testing (POCT) Market

  • 28.1. North America Point-Of-Care-Testing (POCT) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Point-Of-Care-Testing (POCT) Market

  • 29.1. USA Point-Of-Care-Testing (POCT) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Point-Of-Care-Testing (POCT) Market

  • 30.1. Canada Point-Of-Care-Testing (POCT) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Point-Of-Care-Testing (POCT) Market

  • 31.1. South America Point-Of-Care-Testing (POCT) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Point-Of-Care-Testing (POCT) Market

  • 32.1. Brazil Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Point-Of-Care-Testing (POCT) Market

  • 33.1. Middle East Point-Of-Care-Testing (POCT) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Point-Of-Care-Testing (POCT) Market

  • 34.1. Africa Point-Of-Care-Testing (POCT) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Point-Of-Care-Testing (POCT) Market Regulatory and Investment Landscape

36. Point-Of-Care-Testing (POCT) Market Competitive Landscape And Company Profiles

  • 36.1. Point-Of-Care-Testing (POCT) Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Point-Of-Care-Testing (POCT) Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Point-Of-Care-Testing (POCT) Market Company Profiles
    • 36.3.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

37. Point-Of-Care-Testing (POCT) Market Other Major And Innovative Companies

  • Becton Dickinson and Company, BioMerieux SA, QuidelOrtho Corporation, Sysmex Corporation, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, Sinocare Inc., Menarini Diagnostics, Princeton BioMeditech, Helena Laboratories, Chembio Diagnostics, ARKRAY

38. Global Point-Of-Care-Testing (POCT) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Point-Of-Care-Testing (POCT) Market

40. Point-Of-Care-Testing (POCT) Market High Potential Countries, Segments and Strategies

  • 40.1 Point-Of-Care-Testing (POCT) Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Point-Of-Care-Testing (POCT) Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Point-Of-Care-Testing (POCT) Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer